Summary
finding that scienter under the FCA could not be established because defendant's good faith interpretation of a key term in the applicable regulation was reasonable
Summary of this case from United States ex rel. Schutte v. SuperValu, Inc.Opinion
No. 15-17206 No. 15-17478
05-05-2017
NOT FOR PUBLICATION
D.C. No. 2:13-cv-00864-DJH MEMORANDUM Appeal from the United States District Court for the District of Arizona
Diane J. Humetewa, District Judge, Presiding Argued and Submitted April 18, 2017 San Francisco, California Before: D.W. NELSON and IKUTA, Circuit Judges, and BURGESS, Chief District Judge.
This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3.
The Honorable Timothy M. Burgess, United States Chief District Judge for the District of Alaska, sitting by designation.
Mark McGrath, on behalf of the United States of America, appeals the district court's order dismissing his qui tam complaint under Rules 8(a) and 9(b) of the Federal Rules of Civil Procedure and denying leave to amend. We have jurisdiction under 28 U.S.C. § 1291.
McGrath's complaint failed to state a false certification claim under the False Claims Act (FCA), 31 U.S.C. §§ 3729-3733, because the complaint failed to plead facts plausibly alleging that compliance with the International Traffic in Arms Regulations (ITAR) was material to the Government's decision to pay White Electronic Designs Corporation and Microsemi Corporation (collectively, "Microsemi"). Universal Health Servs., Inc. v. United States ex rel. Escobar, 136 S. Ct. 1989, 2002-03 (2016). Moreover, even assuming that the statement "ITAR controlled" on Microsemi's receipts constituted a false representation that Microsemi was in compliance with ITAR, the complaint cannot plead facts sufficient to support an inference that Microsemi knew it had failed to comply with ITAR at the time of the representation because Microsemi's good faith interpretation of the term "disclose" in 22 C.F.R. § 120.17 at that time was reasonable. See Safeco Ins. Co. of Am. v. Burr, 551 U.S. 47, 70 n.20 (2007). Because McGrath cannot establish Microsemi's scienter as a matter of law, and has not indicated what facts he could add to the complaint to establish that Microsemi's alleged ITAR violation was material to the Government's payment decision, the district court did not err in denying leave to amend. See id.; Hildes v. Arthur Andersen LLP, 734 F.3d 854, 859 (9th Cir. 2013).
Finally, McGrath waived his argument that Microsemi provided the Government worthless products by failing to raise it in his opening brief. Martinez-Serrano v. I.N.S., 94 F.3d 1256, 1259 (9th Cir. 1996). To the extent McGrath is now raising the modified argument that Microsemi knowingly demanded payment for products that had lost value due to Microsemi's failure to comply with ITAR, such a claim fails for the same reasons as his false certification claim.
McGrath failed to raise his FCA claim for fraud in the inducement before the district court. We therefore decline to address this issue on appeal. Bolker v. Comm'r of Internal Revenue, 760 F.2d 1039, 1042 (9th Cir. 1985). --------
AFFIRMED.